FindTrial
Sign In

The Value of 18F-AldoView PET CT/MRI in the Diagnosis of Primary Aldosteronism

The Value of 18F-AldoView PET CT/MRI in the Diagnosis of Primary Aldosteronism

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600126274
Enrollment
Unknown
Registered
2026-06-05
Start date
2026-06-05
Completion date
Unknown
Last updated
2026-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

primary aldosteronism

Interventions

Patient group:None

Sponsors

Army Medical Center of PLA
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Age = 18 years; 2.Patients with clinically suspected primary aldosteronism; 3.Underwent paired 18F-AldoView PET/CT and PET/MRI examinations; 4.Received adrenalectomy or adrenal artery embolization, with standardized follow-up for at least 3 months after the procedure;

Exclusion criteria

Exclusion criteria: 1.Unable to maintain supine position, or with contraindications to MRI (e.g., metallic implants, claustrophobia); 2.Planning pregnancy, pregnant, or breastfeeding; 3.Psychiatric disorders, cognitive impairment, or inability to cooperate with the examination and follow-up;

Design outcomes

Primary

MeasureTime frame
Sensitivity;specificity; accuracy;positive predictive value;negative predictive value;—

Countries

China

Contacts

Public ContactXiao Chen

Army Medical Center of PLA

xiaochen229@foxmail.com+86 23 6874 6247

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 11, 2026